MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Release: Menstrual Blood Stem Cells Used to Treat Heart Failure Patients
3/22/2013 9:01:40 AM
More...
|
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Appoints Biotechnology Veteran John Chiplin, Ph.D. to Board of Directors
1/8/2013 9:15:07 AM
More...
|
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Annual Letter to Shareholders
1/4/2013 8:58:06 AM
More...
|
Urologic Surgery Pioneer Dr. Alexander Gershman Joins MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)'s Scientific Advisory Board
11/20/2012 11:08:23 AM
More...
|
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) CEO Dr. Alan Lewis to Present at the Stem Cell Meeting on the Mesa
10/29/2012 6:52:46 AM
More...
|
National Institutes of Health (NIH) Data Suggests MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)'s Stem Cell is Unique From Competitor Stem Cells
10/10/2012 8:48:00 AM
More...
|
Biopharmaceutical Executive Dr. Alan Lewis Appointed as CEO of MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)
10/9/2012 7:10:47 AM
More...
|
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) to Provide Update on Heart Failure Clinical Trial at BIOX; Noble Financial Capital Markets' Life Sciences Exposition
9/21/2012 9:58:10 AM
More...
|
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Advances Type 1 Diabetes Stem Cell Technology Licensed From Yale University School Of Medicine
9/12/2012 10:10:32 AM
More...
|
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Launches Critical Limb Ischemia Clinical Trial
7/13/2012 10:01:22 AM
More...
|
|